Cellulitis Completed Phase 2 Trials for Telavancin (DB06402)

Also known as: Cellulitis, unspecified

IndicationStatusPhase
DBCOND0014773 (Cellulitis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00061633Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)Treatment